Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a One-Session therapy help displaced people avoid substance abuse?

NCT ID NCT07672457

Prevention Sponsor: Boston Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests whether a single session of Acceptance and Commitment Therapy (ACT) can help internally displaced adults manage stress and prevent substance use. Researchers will enroll 144 people who have been displaced by conflict and have used at least one substance (other than alcohol or tobacco) in the past three months. The trial compares the ACT group to a standard health education session to see if the therapy is feasible, acceptable, and shows early signs of reducing substance use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Acceptance and Commitment Therapy (ACT) group therapy
What this could lead to
If effective, this brief therapy could offer a scalable way to prevent substance use disorders in displaced populations.
What could go wrong
This is an early-stage trial focused on feasibility and acceptability, not yet on proven outcomes. The single-session format may be too brief to produce lasting change.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 144 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2027

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 18 or over 2. Have been displaced at least once due to Anti-Terrorist Operation (ATO) or full-scale invasion since 2014 3. Self-reported use of at least one substance other than alcohol and tobacco within the past 3 months 4. Ability to provide informed consent and speak Ukrainian or Russian Exclusion Criteria: 1. Self-reported diagnosis of a substance use disorder 2. Inability to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prevention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

substance-related disorder substance abuse prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prevention Refugee health Substance use

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Alliance for Public Health

    Kyiv, Ukraine

More trials for these conditions

Other studies related to the condition(s) this trial covers.